Abstract:Alternative splicing (AS) serves as a pivotal mechanism in transcriptional regulation, engendering transcript diversity, and modifications in protein structure and functionality. Across varying tissues, developmental stages, or under specific conditions, AS gives rise to distinct splice isoforms. This implies that these isoforms possess unique temporal and spatial roles, thereby associating AS with standard biological activities and diseases. Among these, AS-related RNA-binding proteins (RBPs) play an instrumental role in regulating alternative splicing events. Under physiological conditions, the diversity of proteins mediated by AS influences the structure, function, interaction, and localization of proteins, thereby participating in the differentiation and development of an array of tissues and organs. Under pathological conditions, alterations in AS are linked with various diseases, particularly cancer. These changes can lead to modifications in gene splicing patterns, culminating in changes or loss of protein functionality. For instance, in cancer, abnormalities in AS and RBPs may result in aberrant expression of cancer-associated genes, thereby promoting the onset and progression of tumors. AS and RBPs are also associated with numerous neurodegenerative diseases and autoimmune diseases. Consequently, the study of AS across different tissues holds significant value. This review provides a detailed account of the recent advancements in the study of alternative splicing and AS-related RNA-binding proteins in tissue development and diseases, which aids in deepening the understanding of gene expression complexity and offers new insights and methodologies for precision medicine.

Alternative Splicing As a Biomarker and Potential Target for Drug Discovery

Alternative splicing: Human disease and quantitative analysis from high-throughput sequencing

Therapeutic potential of alternative splicing in cardiovascular diseases

Alternative pre-mRNA splicing in stem cell function and therapeutic potential: A critical review of current evidence

Alternative splicing and related RNA binding proteins in human health and disease

The implications of alternative pre-mRNA splicing in cell signal transduction

Mechanisms of Neuronal Alternative Splicing and Strategies for Therapeutic Interventions

Mechanisms of Alternative Splicing Regulation: Insights from Molecular and Genomics Approaches

Computational approaches for detecting disease-associated alternative splicing events

Alternative splicing of gene transcription and its progress in clinical pharmacology

The role of alternative splicing in human cancer progression.

Genomics of alternative splicing: evolution, development and pathophysiology

Mutually Exclusive Alternative Splicing of Pre‐mrnas

Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics

Aberrant Alternative Splicing in Breast Cancer

RNA Structures in Alternative Splicing and Back‐splicing

Significance of Alternative Splicing in Cancer Cells.

ExonImpact: Prioritizing Pathogenic Alternative Splicing Events.

Alternative Splicing in Lifeomics Era

Alternative splicing and cancer: a systematic review

Development and Disease-Specific Regulation of RNA Splicing in Cardiovascular System